Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Erlotinib/gemcitabine

Lung and skin disorders: case report

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Boeck S, Hausmann A, Reibke R, Schulz C, Heinemann V.Severe interstitial lung disease during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer - a case report. Onkologie 30 (Suppl. 3): 221, Oct 2007 - Germany

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Erlotinib/gemcitabine. React. Wkly. 1182, 17 (2007). https://doi.org/10.2165/00128415-200711820-00051

    Download citation

    Keywords

    • Public Health
    • Patient Outcome
    • Congenital Anomaly
    • Actual Body
    • Body Text